Back
Kymera Therapeutics Stock Predictions
Buy
58
KYMR
Kymera Therapeutics
Last Price:
33.09
Seasonality Move:
25.61%
7 Day Trial
ALL ACCESS PASS
$
7
Kymera Therapeutics Stock Forecast
- Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 8% based on the past 3 years of stock performance.
- Kymera Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Kymera Therapeutics Stock Undervalued?
The current Kymera Therapeutics [KYMR] share price is $32.96. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal. - KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Kymera Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 8% based on the past 3 years of stock performance.
Kymera Therapeutics Stock Rating
Buy
58
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics overpriced?
- Kymera Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Kymera Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com
52-Week Data
52-Week High:
45.31
52-Week Low:
9.60
Prediction Charts
Market Cap:
2.02B
Price in USD:
32.96
Volume:
310.11K
Beta:
2.23
Technical Analysis
SMA50:
35.42
SMA100:
36.43
SMA200:
27.67
52-Wk Change:
29.97%
Stock Predictions
-
Is Kymera Therapeutics stock public?
Yes, Kymera Therapeutics is a publicly traded company. -
What is the Kymera Therapeutics stock quote today?
The Kymera Therapeutics stock price is 32.96 USD today. -
How to buy Kymera Therapeutics stock online?
You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-20 | 35.02 | 36.01 | 36.86 | 35.00 |
May-21 | 35.75 | 35.32 | 36.31 | 35.08 |
May-22 | 35.10 | 35.70 | 36.24 | 34.36 |
May-23 | 35.98 | 34.24 | 35.98 | 33.72 |
May-24 | 34.38 | 34.05 | 36.00 | 33.94 |
May-28 | 34.43 | 33.52 | 34.43 | 33.04 |
May-29 | 32.92 | 32.45 | 33.28 | 32.26 |
May-30 | 32.94 | 32.16 | 32.94 | 31.63 |
May-31 | 32.25 | 32.11 | 33.02 | 31.47 |
Jun-3 | 32.49 | 31.56 | 33.24 | 30.98 |
Jun-4 | 31.46 | 31.94 | 32.59 | 31.15 |
Jun-5 | 32.24 | 33.87 | 34.00 | 31.76 |
Jun-6 | 33.69 | 32.87 | 33.69 | 32.25 |
Jun-7 | 32.44 | 32.96 | 33.46 | 32.27 |
Kymera Therapeutics Earnings
Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Kymera Therapeutics Forecast Revenue Growth
Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.31 per share.
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.